Related references
Note: Only part of the references are listed.Screening for Hepatitis C Virus Infection in Adults: A Systematic Review for the U. S. Preventive Services Task Force
Roger Chou et al.
ANNALS OF INTERNAL MEDICINE (2013)
Reducing Risk for Mother-to-Infant Transmission of Hepatitis C Virus: A Systematic Review for the US Preventive Services Task Force
Erika Barth Cottrell et al.
ANNALS OF INTERNAL MEDICINE (2013)
Hepatitis C virus infection in an endemic area of Southern Italy 14 years later: Evidence for a vanishing infection
Vincenzo Guadagnino et al.
DIGESTIVE AND LIVER DISEASE (2013)
Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence
Khayriyyah Mohd Hanafiah et al.
HEPATOLOGY (2013)
Sexual transmission of hepatitis C virus among monogamous heterosexual couples: The HCV partners study
Norah A. Terrault et al.
HEPATOLOGY (2013)
Transmission of Hepatitis C Virus Among People Who Inject Drugs: Viral Stability and Association With Drug Preparation Equipment
Juliane Doerrbecker et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
Edward J. Gane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Integrating Phylodynamics and Epidemiology to Estimate Transmission Diversity in Viral Epidemics
Gkikas Magiorkinis et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in US Primary Care Settings
David B. Rein et al.
ANNALS OF INTERNAL MEDICINE (2012)
Hepatitis C Virus Testing of Persons Born During 1945-1965: Recommendations From the Centers for Disease Control and Prevention
Bryce D. Smith et al.
ANNALS OF INTERNAL MEDICINE (2012)
New Protease Inhibitors for the Treatment of Chronic Hepatitis C A Cost-Effectiveness Analysis
Shan Liu et al.
ANNALS OF INTERNAL MEDICINE (2012)
Accuracy of Rapid and Point-of-Care Screening Tests for Hepatitis C A Systematic Review and Meta-analysis
Sushmita Shivkumar et al.
ANNALS OF INTERNAL MEDICINE (2012)
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Hashem B. El-Serag
GASTROENTEROLOGY (2012)
Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008
Maxine M. Denniston et al.
HEPATOLOGY (2012)
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
Adriaan J. van der Meer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Gaps in the achievement of effectiveness of HCV treatment in national VA practice
Jennifer R. Kramer et al.
JOURNAL OF HEPATOLOGY (2012)
Chronic Hepatitis C Virus Infection Increases Mortality From Hepatic and Extrahepatic Diseases: A Community-Based Long-Term Prospective Study
Mei-Hsuan Lee et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
Anna S. Lok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Fifteen-Year Population Attributable Fractions and Causal Pies of Risk Factors for Newly Developed Hepatocellular Carcinomas in 11,801 Men in Taiwan
Shu-Fen Liao et al.
PLOS ONE (2012)
Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis
Patrizia Farci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Incidence and Transmission Patterns of Acute Hepatitis C in the United States, 1982-2006
Ian T. Williams et al.
ARCHIVES OF INTERNAL MEDICINE (2011)
A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C
Lisa I. Backus et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States
David B. Rein et al.
DIGESTIVE AND LIVER DISEASE (2011)
Direct Economic Burden of Chronic Hepatitis C Virus in a United States Managed Care Population
Keith L. Davis et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)
Changes in Blood-borne Infection Risk Among Injection Drug Users
Shruti H. Mehta et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Test and treat this silent killer
Brian R. Edlin
NATURE (2011)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Sexual Transmission of Hepatitis C Virus in Human Immunodeficiency Virus-Negative Men Who Have Sex With Men: A Series of Case Reports
Thijs J. W. van de Laar et al.
SEXUALLY TRANSMITTED DISEASES (2011)
The principles and feasibility of disease eradication
Walter R. Dowdle et al.
VACCINE (2011)
Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
Gary L. Davis et al.
GASTROENTEROLOGY (2010)
Reinfection with hepatitis C virus following sustained virological response in injection drug users
Jason Grebely et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis
Ana-Carolina Cardoso et al.
JOURNAL OF HEPATOLOGY (2010)
Survival of Hepatitis C Virus in Syringes: Implication for Transmission among Injection Drug Users
Elijah Paintsil et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Attribution of Hepatitis C Virus Seroconversion Risk in Young Injection Drug Users in 5 US Cities
Holly Hagan et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Sustained Responders Have Better Quality of Life and Productivity Compared With Treatment Failures Long After Antiviral Therapy for Hepatitis C
Ava A. John-Baptiste et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Nonhospital Health Care-Associated Hepatitis B and C Virus Transmission: United States, 1998-2008
Nicola D. Thompson et al.
ANNALS OF INTERNAL MEDICINE (2009)
Evidence of a Large, International Network of HCV Transmission in HIV-Positive Men Who Have Sex With Men
Thijis van de Laar et al.
GASTROENTEROLOGY (2009)
Public Health Impact of Antiviral Therapy for Hepatitis C in the United States
Michael L. Volk et al.
HEPATOLOGY (2009)
Sustained Virological Response to Interferon Plus Ribavirin Reduces Liver-Related Complications and Mortality in Patients Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus
Juan Berenguer et al.
HEPATOLOGY (2009)
Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality
E. M. Lehman et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Estimating the incidence, prevalence and clinical burden of hepatitis C over time in Italy
Andrea Mariano et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2009)
Market uptake of new antiviral drugs for the treatment of hepatitis C
Beate Lettmeier et al.
JOURNAL OF HEPATOLOGY (2008)
Novel advancements in the management of hepatocellular carcinoma in 2008
Josep M. Llovet et al.
JOURNAL OF HEPATOLOGY (2008)
Liver fibrosis during an outbreak of acute hepatitis c virus infection in HIV-infected men: A prospective cohort study
Daniel S. Fierer et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis
Bart J. Veldt et al.
ANNALS OF INTERNAL MEDICINE (2007)
Hepatitis C virus infections from a contaminated radiopharmaceutical used in myocardial perfusion studies
Priti R. Patel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
Joseph F. Perz et al.
JOURNAL OF HEPATOLOGY (2006)
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
Gregory L. Armstrong et al.
ANNALS OF INTERNAL MEDICINE (2006)
Liver disease in Egypt: Hepatitis C superseded schistosomiasis as a result of latrogenic and biological factors
GT Strickland
HEPATOLOGY (2006)
Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality
Y Tanaka et al.
GASTROENTEROLOGY (2006)
Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy
EE Mast et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Viral and host factors in early hepatitis C virus infection
JW Mosley et al.
HEPATOLOGY (2005)
Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment
BMR Spiegel et al.
HEPATOLOGY (2005)
Prospective evaluation of community-acquired acute-phase hepatitis C virus infection
AL Cox et al.
CLINICAL INFECTIOUS DISEASES (2005)
Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling
E Foy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Hepatitis C virus infection among injection drug users - Survival analysis of time to seroconversion
H Hagan et al.
EPIDEMIOLOGY (2004)
The global burden of disease attributable to contaminated injections given in health care settings
AM Hauri et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2004)
Lack of evidence of sexual transmission of hepatitis C among monogamous couples:: Results of a 10-year prospective follow-up study
C Vandelli et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system
J Baillargeon et al.
PUBLIC HEALTH (2003)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients
D Bernstein et al.
HEPATOLOGY (2002)
Costs of hepatitis C
JP Leigh et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection
S Barrett et al.
GUT (2001)
Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States
SH Mehta et al.
ANNALS OF INTERNAL MEDICINE (2000)
Estimating future hepatitis C morbidity, mortality, and costs in the United States
JB Wong et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2000)
The natural history of hepatitis C virus infection - Host, viral, and environmental factors
DL Thomas et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy
Y Shiratori et al.
ANNALS OF INTERNAL MEDICINE (2000)
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
C Frank et al.
LANCET (2000)
Share Paper
